Literature DB >> 31062428

Psoriasis is associated with increased risk of bullous pemphigoid: A nationwide population-based cohort study in Taiwan.

Yi-Hsin Ho1,2, Hsiao-Yun Hu3,4, Yun-Ting Chang1,2, Chung-Pin Li2,5, Chen-Yi Wu1,2,3.   

Abstract

Psoriasis may coexist with bullous pemphigoid (BP); however, no cohort studies have investigated the relationship between psoriasis and the risk of BP. This study aims to investigate the relationship between psoriasis and the risk of BP in Taiwan. This cohort study consists of 109 777 psoriatic patients and 109 777 matched non-exposed controls. Psoriatic patients diagnosed between 2002 and 2012 were identified from the Taiwan National Health Insurance Research Database. The age-, sex- and index date-matched non-exposed group was selected from the same database. The relationship between psoriasis and the risk of BP was investigated using Cox proportional hazards analyses. Psoriasis was significantly associated with an increased risk of BP (hazard ratio, 3.05; 95% confidence interval, 2.10-4.43; P < 0.001). The mean interval between the diagnoses of psoriasis and BP was 2.86 years, with the highest occurrence in the first year after psoriasis diagnosis, and gradually decreasing with each year of observation. Psoriatic patients with BP were significantly younger than BP patients in the non-exposed group (71.6 ± 13.9 vs 76.6 ± 7.7 years, respectively; P = 0.030). A higher proportion of patients with coexisting psoriasis and BP received phototherapy (20%). In conclusion, psoriasis was independently associated with a 3.05-fold increased risk of BP, and psoriatic patients with BP were younger, with over one-third of BP cases diagnosed in the first year after incident psoriasis. Therefore, clinicians treating patients with psoriasis may be aware of the possibility of the development of BP.
© 2019 Japanese Dermatological Association.

Entities:  

Keywords:  bullous pemphigoid; cohort study; immunosuppressant; phototherapy; psoriasis

Mesh:

Year:  2019        PMID: 31062428     DOI: 10.1111/1346-8138.14902

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  6 in total

Review 1.  Bullous pemphigoid: An immune disorder related to aging (Review).

Authors:  Maria Ludovica Deotto; Alice Spiller; Alvise Sernicola; Mauro Alaibac
Journal:  Exp Ther Med       Date:  2021-11-15       Impact factor: 2.447

Review 2.  Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review.

Authors:  Jin Bu; Ruilian Ding; Liangjia Zhou; Xiangming Chen; Erxia Shen
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

Review 3.  Case Report: Bullous Pemphigoid Associated With Morphea and Lichen Sclerosus: Coincidental Diseases or Pathogenetic Association?

Authors:  Roberto Maglie; Maria Efenesia Baffa; Francesca Montefusco; Carlo Pipitò; Stefano Senatore; Marco Capassoni; Vincenza Maio; Marco Matucci Cerinic; Emiliano Antiga; Serena Guiducci
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

Review 4.  Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis.

Authors:  Masutaka Furue; Akiko Hashimoto-Hachiya; Gaku Tsuji
Journal:  Int J Mol Sci       Date:  2019-10-31       Impact factor: 5.923

5.  UVB-induced bullous pemphigoid in a patient with psoriasis.

Authors:  Justyna Ceryn; Małgorzata Skibińska; Paulina Barasiñska; Marcin Noweta; Joanna Narbutt; Aleksandra Lesiak
Journal:  Postepy Dermatol Alergol       Date:  2020-09-15       Impact factor: 1.837

Review 6.  Bullous Pemphigoid: Trigger and Predisposing Factors.

Authors:  Francesco Moro; Luca Fania; Jo Linda Maria Sinagra; Adele Salemme; Giovanni Di Zenzo
Journal:  Biomolecules       Date:  2020-10-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.